Back to search
FDAFDA · Food and drugs·Recall number D-1329-2015

Cytarabine Injection 100 mg/5 mL (20 mg/mL), 5 mL Single-Dose Vial (NDC 0069-0152-01), packaged in 10 x 5 mL Vials per carton (NDC 0069-0152-02), Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017.

Published August 19, 2015 · Recall initiated: April 23, 2015

Summary

FDA records drug Class I recall D-1329-2015, published August 19, 2015 and initiated April 23, 2015. Recalling firm: Mylan Institutional LLC; Status: Terminated; Reported quantity: 8,340 vials; Lot: Lot # 7801050, Exp. Date. 05/2015. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Institutional LLC
Distributor
Nationwide
Lot
Lot # 7801050, Exp. Date. 05/2015
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cytarabine Injection 100 mg/5 mL (20 mg/mL), 5 mL Single-Dose Vial (NDC 0069-0152-01), packaged in 10 x 5 mL Vials per carton (NDC 0069-0152-02), Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017. recalled?

Yes. FDA published recall D-1329-2015 on August 19, 2015. Reported hazard: Presence of Particulate Matter

What should I do if I have this product?

Voluntary: Firm initiated · Press Release